Non-Cystic Fibrosis Bronchiectasis
Rare Disease·MeSH: Bronchiectasis
Prevalence
4.0 / 100K
Incidence
3.5 / 100K/yr
5 drugs in development·4 companies·4 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| BRINSUPRI | INSMED Inc (INSM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Non-Cystic Fibrosis Bronchiectasis?
BioSniper tracks 5 drugs in development for Non-Cystic Fibrosis Bronchiectasis across 4 companies.
How many clinical trials target Non-Cystic Fibrosis Bronchiectasis?
There are 4 clinical trials targeting Non-Cystic Fibrosis Bronchiectasis tracked by BioSniper.
What is the prevalence of Non-Cystic Fibrosis Bronchiectasis?
The estimated prevalence of Non-Cystic Fibrosis Bronchiectasis is approximately 4.0 per 100,000 population.
Deep-dive into Non-Cystic Fibrosis Bronchiectasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis